New drug combo tested for Tough-to-Treat breast cancer
Disease control
Recruiting now
This is a small, early-stage study to find a safe dose of two drugs—olaparib and estradiol—when used together for advanced breast cancer that is hormone-sensitive but has stopped responding to standard hormone treatments. It will involve about 6 post-menopausal women. The main go…
Phase: PHASE1 • Sponsor: Mary D Chamberlin • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC